CYH vs THC Stock Comparison: AI Score, Valuation, Performance and Upside
CYH (Community Health Systems) and THC (Tenet Healthcare) are both large for-profit hospital operators, but with very different financial situations and market positioning — CYH operates primarily in non-urban markets with higher financial leverage, while Tenet operates in better payer-mix urban/suburban markets with a higher-growth ambulatory surgery center business through USPI.
CYH vs THC compares two challenged for-profit hospital operators at different quality tiers — Community Health Systems' distressed but potentially recovering non-urban hospital portfolio versus Tenet's stronger urban hospitals and growing high-margin ambulatory surgery business.
THC holds the edge across 5 of 5 key metrics in this comparison. THC leads on both 1-year return (+32.42%) and forward P/E quality (12.26x vs -5.59x for CYH), a relatively favorable combination of momentum and valuation. THC leads on both revenue growth (6.80%) and operating margin (18.16%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies similar upside for both: +9.80% for CYH and +10.28% for THC.
Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.
- Want high-leverage turnaround exposure to non-urban hospital operations with potentially significant upside if debt is reduced
- Believe supplemental Medicaid payments and government healthcare support will sustain rural hospital economics
- Are comfortable with significant financial and operational risk in exchange for a deeply discounted valuation
- Want for-profit hospital operator exposure with the additional benefit of USPI's ambulatory surgery center growth business
- Value Tenet's better urban/suburban payer mix and higher-margin ambulatory strategy versus pure hospital operators
- See USPI monetization as a potential catalyst for deleveraging and value realization in Tenet's sum-of-parts valuation
| Metric | CYH | THC |
|---|---|---|
| AI scorei | 24.4 | 72.6 |
| AI ranki | #3081 | #28 |
| Latest closei | $2.05 | $266.69 |
| 1M returni | -24.63% | +3.12% |
| 3M returni | -30.74% | +5.27% |
| 6M returni | -27.30% | +42.68% |
| 1Y returni | -46.75% | +32.42% |
How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?
| Period | CYH | THC |
|---|---|---|
| 1Y ago | $5.32K (-46.8%) started 2025-11-03 | $12.84K (+28.4%) started 2025-11-04 |
| 5Y ago | $1.5K (-85.0%) started 2021-11-04 | $36.67K (+266.7%) started 2021-11-04 |
| 10Y ago | $3.7K (-63.0%) started 2016-11-04 | $150.25K (+1402.5%) started 2016-11-04 |
Hypothetical — past performance does not guarantee future results.
| Metric | CYH | THC |
|---|---|---|
| Market capi | $408.22M | $20.82B |
| Trailing P/Ei | 1.56 | 9.99 |
| Forward P/Ei | -5.59 | 12.26 |
| Price/Salesi | N/A | N/A |
| EV/Revenuei | 0.92 | 1.65 |
| Analyst targeti | $3.18 | $285.10 |
| Target upsidei | +9.80% | +10.28% |
| Metric | CYH | THC |
|---|---|---|
| Revenue growthi | -9.80% | 6.80% |
| Earnings growthi | -75.60% | 213.40% |
| EPS growthi | -75.60% | +213.40% |
| FCF margini | +1.65% | +10.31% |
| Operating margini | 7.68% | 18.16% |
| Profit margini | 2.10% | 10.27% |
| ROIC proxyi | N/A | 37.34% |
| Return on equityi | N/A | 37.34% |
| Dividend yieldi | N/A | N/A |
| Payout ratioi | 0.00% | 0.00% |
| Dividend growth streaki | N/A | N/A |
| Betai | 1.86 | 1.23 |
| Debt/equityi | N/A | 152.28 |
| Current ratioi | 1.53 | 1.41 |
| Quick ratioi | 1.20 | 1.15 |
Over the past year, CYH and THC have moved weakly in the same direction (correlation of 0.33), based on daily returns.
Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.
| Period | Metric | CYH | THC |
|---|---|---|---|
| 1Y | Growthi | -46.75% | +28.38% |
| CAGRi | -46.78% | +28.44% | |
| Volatilityi | 51.53% | 42.98% | |
| Sharpe ratioi | -1.05 | 0.69 | |
| Sortino ratioi | -1.34 | 1.26 | |
| Max drawdowni | 47.44% | 34.08% | |
| Current drawdowni | 47.44% | 5.01% | |
| Avg drawdowni | 20.71% | 11.80% | |
| Ulcer Indexi | 22.05% | 15.10% | |
| Max daily dropi | 13.66% | 5.71% | |
| Max wkly dropi | 28.57% | 13.37% | |
| 5Y | Growthi | -85.01% | +266.74% |
| CAGRi | -31.60% | +29.69% | |
| Volatilityi | 77.98% | 44.92% | |
| Sharpe ratioi | -0.15 | 0.71 | |
| Sortino ratioi | -0.21 | 1.03 | |
| Max drawdowni | 86.28% | 58.88% | |
| Current drawdowni | 86.28% | 5.01% | |
| Avg drawdowni | 70.32% | 16.62% | |
| Ulcer Indexi | 72.74% | 22.20% | |
| Max daily dropi | 42.86% | 30.96% | |
| Max wkly dropi | 44.14% | 28.74% | |
| 10Y | Growthi | -63.00% | +1402.48% |
| CAGRi | -9.47% | +31.13% | |
| Volatilityi | 81.49% | 56.35% | |
| Sharpe ratioi | 0.23 | 0.68 | |
| Sortino ratioi | 0.34 | 1.03 | |
| Max drawdowni | 87.69% | 71.68% | |
| Current drawdowni | 87.69% | 5.01% | |
| Avg drawdowni | 58.93% | 20.13% | |
| Ulcer Indexi | 64.30% | 25.88% | |
| Max daily dropi | 42.86% | 30.96% | |
| Max wkly dropi | 47.62% | 44.92% |
| Category | CYH | THC |
|---|---|---|
| Company | Community Health Systems, Inc. | Tenet Healthcare Corporation |
| Sector | Healthcare | Healthcare |
| Industry | Medical Care Facilities | Medical Care Facilities |
| Core business | Community Health Systems operates a network of acute care hospitals primarily in non-urban and mid-sized markets across the U.S., providing inpatient and outpatient healthcare services to communities with limited access to other hospital care. | Tenet Healthcare operates acute care hospitals, surgical hospitals, and ambulatory surgery centers (through its USPI ambulatory segment), providing healthcare services across a mix of urban and suburban markets with a significant focus on higher-margin ambulatory care. |
| Investor focus | Investors track CYH's same-hospital revenue per adjusted admission trends, operating margins, debt reduction progress, and hospital divestiture strategy as the company reduces its hospital portfolio to improve focus and financial health. | Investors track Tenet's USPI ambulatory surgery center revenue growth, hospital same-facility volume and revenue per patient, EBITDA margin improvements, and leverage reduction through USPI monetization or hospital divestitures. |
- Community hospitals in non-urban markets often have limited local competition, providing a degree of regional market protection
- Government supplemental Medicaid payments (Disproportionate Share Hospital payments) support revenue for hospitals serving high-uninsured populations
- Portfolio rationalization through divesting underperforming hospitals is improving the overall quality and margin profile of remaining facilities
- USPI ambulatory surgery center business operates in higher-margin, faster-growing ambulatory surgery settings rather than just traditional hospital settings
- Urban and suburban market mix provides better payer dynamics than Community Health Systems' non-urban focus
- USPI has been growing through acquisitions of ambulatory surgery centers, a structurally attractive segment as procedures shift from hospitals to ambulatory settings
- Extremely high debt load from historical acquisitions creates significant financial risk in difficult operating environments
- Non-urban markets often have less favorable payer mixes (more Medicaid and uninsured) than urban markets served by HCA and Tenet
- Physician recruitment and nursing staffing challenges in non-urban markets are more acute than at urban hospital systems
- Significant debt load constrains financial flexibility similar to CYH, though Tenet's margins are stronger
- Hospital industry faces ongoing labor cost inflation from nursing travel staffing and specialty physician compensation
- Regulatory and reimbursement uncertainty from government payer programs (Medicare, Medicaid) affects the entire for-profit hospital sector
Compare more than two at a time
This page is a fixed writeup on CYH and THC. Our comparison engine is the interactive version: load up to five tickers, switch timeframes, and get the correlation, drawdown, and overlap analysis that a static page can't show.
Add three more names beside CYH and THC, mixing stocks and ETFs in the same table — useful when the real question is which of a whole peer group to own.
AI score, forward P/E, analyst target upside, operating margin, and revenue growth are scored head-to-head, with a running tally of which ticker leads on how many metrics.
Volatility, Sharpe and Sortino ratios, maximum, current, and average drawdown, Ulcer Index, and worst single-day and single-week drops across every timeframe.
Pairwise daily-return correlation for every combination, so you can see whether two holdings actually diversify each other or just move together.
A scatter plot of forward P/E against return on equity, plus drawdown and 30-day rolling volatility charts, to separate what is cheap from what is merely beaten down.
For ETFs, a top-holdings comparison that exposes hidden overlap between funds. Every comparison exports to CSV for your own spreadsheet work.
Two comparisons a week are free without an account. A 14-day trial removes the limit and adds AI price forecasts, stock rankings, saved watchlists, and the intrinsic value calculator — no credit card required.
Want deeper AI forecasts?
This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.